The Technical Analyst
Teligent Inc (NEW JERSEY) [TLGT]
Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Teligent Inc (NEW JERSEY) Price, Forecast, Insider, Ratings, Fundamentals & Signals
-13.85% $0.174
America/New_York / 31 des 1970 @ 19:00
| RATING 2022-02-09 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Sell | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 1/20 | 2/20 | 3/20 | 4/20 | 1/21 | 2/21 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.0403 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.00x |
| Company: PE -0.0403 | industry: PE 47.78 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.147 - 0.201 ( +/- 15.56%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-07-21 | Ben-maimon Carole | Buy | 150 000 | Restricted Stock Units |
| 2021-07-21 | Celentano John E | Buy | 150 000 | Restricted Stock Units |
| 2021-07-21 | Marth William S | Buy | 150 000 | Restricted Stock Units |
| 2021-07-21 | Pate R Carter | Buy | 150 000 | Restricted Stock Units |
| 2021-07-16 | Yachmetz Philip K | Buy | 7 835 | Restricted Stock Units |
| INSIDER POWER |
|---|
| 0.00 |
| Last 94 transactions |
| Buy: 6 929 847 | Sell: 975 703 |
Forecast:
01:40 - $0.305
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $0.174 (-13.85% ) |
| Volume | 72.25 mill |
| Avg. Vol. | 7.97 mill |
| % of Avg. Vol | 905.99 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For TLGT
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
TLGT
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.
Latest Press Releases
2021-08-16 07:00:00 - Press Release
Teligent, Inc. Announces Second Quarter 2021 Earnings Report And Provides Business Update
Buena, n.j., aug. 16, 2021 (globe newswire) -- teligent, inc. (nasdaq: tlgt), a new jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update.
2021-06-18 11:00:00 - Press Release
Teligent, Inc. Announces Adjournment Of Annual Meeting Of Stockholders
Scheduled to reconvene on june 30, 2021 company urgently encourages stockholders to vote
2021-05-21 16:30:00 - Press Release
Teligent, Inc. To Hold Conference Call For First Quarter 2021 Financial Results On Tuesday May 25, 2020
Buena, n.j., may 21, 2021 (globe newswire) -- teligent, inc. (nasdaq: tlgt), ("teligent" or the "company"), a new jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30am et on tuesday, may 25th, 2021 to discuss the first quarter ended march 31, 2021 financial results and business update.
2021-05-03 18:45:00 - Press Release
Teligent, Inc. Announces 2020 Year-end Earnings Report And Provides Business Update
Buena, n.j., may 03, 2021 (globe newswire) -- teligent, inc. (nasdaq: tlgt), a new jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year ended december 31, 2020.
2021-02-16 07:30:00 - Press Release
Teligent, Inc. Announces Appointment Of William S. Marth To Board Of Directors
Buena, n.j., feb. 16, 2021 /prnewswire/ -- teligent, inc. (nasdaq: tlgt), ("teligent" or the "company"), a new jersey-based specialty generic pharmaceutical company, today announced it has appointed industry veteran william s. marth to its board of directors, effective immediately. mr....
Latest News
2021-10-15 07:13:54 - Pulse2
TLGT Stock: Why The Price Substantially Fell
The stock price of Teligent Inc (NASDAQ: TLGT) fell over 39% yesterday. This is why it happened.
2021-09-19 14:00:00 - PennyStocks
Top Penny Stocks to Buy Right Now? 3 to Check Out This Month
Are these top penny stocks to watch on your list in September? The post Top Penny Stocks to Buy Right Now?
2021-08-16 11:08:06 - Seeking Alpha
Teligent, Inc. (TLGT) CEO Tim Sawyer on Q2 2021 Results - Earnings Call Transcript
2021-08-16 07:00:00 - GlobeNewsWire
Teligent, Inc. Announces Second Quarter 2021 Earnings Report and Provides Business Update
BUENA, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the second quarter of 2021 and provided a business update.
2021-06-18 11:00:00 - GlobeNewsWire
Teligent, Inc. Announces Adjournment of Annual Meeting of Stockholders
2021-06-02 09:03:41 - PennyStocks
Trading Biotech Penny Stocks? Check These 3 Out
Biotech penny stocks are heating up as Covid cases decline; which small-caps are on your watchlist? The post Trading Biotech Penny Stocks?
2021-05-25 14:12:03 - Seeking Alpha
Teligent's (TLGT) CEO Tim Sawyer on Q1 2021 Results - Earnings Call Transcript
2021-05-25 07:32:31 - Benzinga
Teligent: Q1 Earnings Insights
Shares of Teligent (NASDAQ:TLGT) rose 1.1% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 13.04% year over year to ($0.26), which may not compare to the estimate of ($2.11).
2021-05-21 16:30:00 - GlobeNewsWire
Teligent, Inc. to Hold Conference Call for First Quarter 2021 Financial Results on Tuesday May 25, 2020
BUENA, N.J., May 21, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT), ("Teligent" or the "Company"), a New Jersey based generics pharmaceutical company, today announced they will hold a conference call at 8:30AM ET on Tuesday, May 25th, 2021 to discuss the first quarter ended March 31, 2021 financial results and business update.
2021-05-03 18:45:00 - GlobeNewsWire
Teligent, Inc. Announces 2020 Year-End Earnings Report and Provides Business Update
BUENA, N.J., May 03, 2021 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based generics pharmaceutical company, today announced its financial results for the fourth quarter and year ended December 31, 2020.